Page last updated: 2024-08-25

n-acetylcysteinamide and dalcetrapib

n-acetylcysteinamide has been researched along with dalcetrapib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Benčina, M; Bergant, V; Govednik, T; Grass, V; Hafner-Bratkovič, I; Jazbec, V; Jerala, R; Lainšček, D; Manček-Keber, M; Orehek, S; Pichlmair, A; Plaper, T	1

Other Studies

1 other study(ies) available for n-acetylcysteinamide and dalcetrapib

Article	Year
Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021, Volume: 35, Issue:6 Topics: Acetylcysteine; Amides; Ascorbic Acid; Auranofin; COVID-19; COVID-19 Drug Treatment; Disulfides; Esters; HEK293 Cells; Humans; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Sulfhydryl Compounds; Virus Internalization	2021

Article

Year

Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021, Volume: 35, Issue:6

Topics: Acetylcysteine; Amides; Ascorbic Acid; Auranofin; COVID-19; COVID-19 Drug Treatment; Disulfides; Esters; HEK293 Cells; Humans; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Sulfhydryl Compounds; Virus Internalization

2021